Recent News

• 06.05.2025 - Jefferies Global Healthcare Conference 2025
• 06.05.2025 - Jefferies Global Healthcare Conference 2025
• 06.04.2025 - Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
• 06.04.2025 - Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
• 06.02.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 06.02.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.28.2025 - Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
• 05.28.2025 - Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
• 05.27.2025 - Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
• 05.27.2025 - Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025

Recent Filings

• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]